文章摘要
淋巴结阳性宫颈癌患者同步整合和序贯加量调强放疗的剂量学比较
Dosimetric study of simultaneously integrated boost intensity-modulated radiotherapy and sequential IMRT for lymph-node positive cervical cancer
投稿时间:2016-11-29  
DOI:10.3969/j.issn.1000-0399.2017.06.010
中文关键词: 宫颈癌  同步加量  调强放疗  剂量学
英文关键词: Cervical neoplasm  Simultaneous integrated boost  Intensity-modulated Radiotherapy  Dosimetry
基金项目:
作者单位E-mail
陈冉 230022 合肥 安徽医科大学第一附属医院放疗科  
权循凤 230022 合肥 安徽医科大学第一附属医院放疗科 xunfengquan@163.com 
陈香存 230022 合肥 安徽医科大学第一附属医院放疗科  
摘要点击次数: 2026
全文下载次数: 0
中文摘要:
      目的 探讨同步加量调强放疗(SIB-IMRT)与序贯加量调强放疗(sIMRT)在盆腔淋巴结阳性宫颈癌放射治疗中的剂量学差异。方法 选取安徽医科大学第一附属医院2015年9月至2016年8月收治的10例腹盆腔淋巴结阳性宫颈癌初治患者,分别设计SIB-IMRT和sIMRT计划,观察SIB-IMRT和sIMRT的靶区和危及器官的剂量学差异。结果 SIB-IMRT和sIMRT的靶区剂量均能满足处方剂量要求,SIB-IMRT的pGTVnd和PTV的适形性指数均高于sIMRT(P<0.05)。与sIMRT比较,SIB-IMRT对股骨头、小肠和直肠的V50、Dmax均较低(P<0.05)。SIB-IMRT对膀胱的V30为(68.91±8.62)%,高于sIMRT,差异有统计学意义(P<0.05)。但SIB-IMRT与sIMRT对膀胱的Dmax、Dmean、V40、V50差异均无统计学意义(P>0.05)。结论 SIB-IMRT计划可用于盆腔淋巴结阳性宫颈癌的治疗,其具有更好的适形性,且对危及器官股骨头、小肠、直肠的保护更好,但其临床疗效尚需进一步验证。
英文摘要:
      Objective To compare the dosimetric differences of simultaneous integrated boost intensity-modulated radiotherapy and sequential IMRT for lymph-node positive cervical cancer. Methods From Sept 2015 to Augu2016,10 cervical cancer patients with positive lymph nodeswere selected in the First Affiliated Hospital of Anhui Medical University,and all patients underwentinitialdiagnosis. All patients were designed two plans of SIB-IMRT and sIMRT techniques,then the dosimetric parameterswerecomparedin terms of volume target and organ at risk of plans.Results All plans could achieve the clinically acceptable target coverage. The conformity index (CI) of the pGTVnd and PTV in SIB-IMRT was significantly better than that of the sIMRT,and the difference was statistically significant (P<0.05). The V50 andthe maximum dose of the femoral head, small intestine and the rectal of SIB-IMRT were all significantly lower than those of sIMRT(P<0.05).The V30 of SIB-IMRTwas(68.91±8.62, which was higher than the V30 of sIMRT significantly.There was no significant difference between the two methods in items of V40,V50, mean doses and maximum dose of bladder,but the V30 was higher in SIB-IMRT. Conclusion SIB-IMRT can be used for cervical cancer patients with positive lymph nodes,and the CI is better, the better protection of the femoral head,small intestine and the rectalcan be achieved.But the clinical outcome and toxicity needs more research.
查看全文   查看/发表评论  下载PDF阅读器
关闭